{"gene":"HCLS1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1993,"finding":"HS1 (p75HS1) was identified as a major substrate of protein-tyrosine kinases in B-cell antigen receptor signaling, undergoing rapid tyrosine phosphorylation and associating with the Src-like kinase Lyn after crosslinking of membrane-bound IgM.","method":"Protein purification, peptide microsequencing, immunoprecipitation, Western blot","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with Lyn, peptide sequencing confirming identity, replicated in subsequent studies","pmids":["7682714"],"is_preprint":false},{"year":1995,"finding":"HS1-deficient mice generated by gene targeting showed impaired antigen receptor-induced clonal expansion of B and T cells and defective clonal deletion (thymic negative selection and peritoneal B cell apoptosis), establishing HS1 as essential for antigen receptor signaling pathways leading to both proliferation and apoptosis.","method":"Gene targeting (knockout mice), proliferation assays, apoptosis assays, crossing with TCR transgenic mice","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with multiple specific phenotypic readouts, foundational study","pmids":["7641686"],"is_preprint":false},{"year":1995,"finding":"Re-expression of HS1 in an anti-IgM-resistant WEHI-231 variant (which had dramatically reduced HS1 levels) restored sensitivity to BCR-mediated apoptosis, demonstrating HS1 is required downstream of BCR for the apoptotic signal.","method":"Expression vector transfection, apoptosis assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function and rescue experiment with defined molecular phenotype","pmids":["7638185"],"is_preprint":false},{"year":1996,"finding":"p72Syk phosphorylates HS1 at sites containing motifs recognized by SH2 domains of Src kinases; this primary phosphorylation converts HS1 into a substrate for Src-family kinases (c-Fgr, Lyn, Fyn), which carry out secondary phosphorylation via SH2-domain-mediated docking. This sequential two-kinase mechanism requires SH2-phosphotyrosine interaction, not catalytic-site recognition.","method":"In vitro kinase assay, phosphopeptide competition, co-immunoprecipitation","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mechanistic dissection using phosphopeptide competition; replicated across multiple Src kinases","pmids":["8611520"],"is_preprint":false},{"year":1996,"finding":"Lck SH3 domain binds HS1 constitutively via its proline-rich region, while the Lck SH2 domain associates with HS1 only upon TCR stimulation (after tyrosine phosphorylation); Fyn SH2 similarly binds phospho-HS1 upon TCR stimulation but Fyn SH3 does not interact.","method":"Co-immunoprecipitation, domain-binding analysis in T cell lines","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 3 — single-lab Co-IP with domain-level mapping, moderate mechanistic detail","pmids":["8943564"],"is_preprint":false},{"year":1997,"finding":"HS1 interacts directly with HAX-1 (a novel mitochondrial/ER/nuclear envelope protein); association is mediated by the N-terminal region of HS1 and the C-terminal half of HAX-1, confirmed by co-immunoprecipitation and co-localization.","method":"Yeast two-hybrid screen, co-immunoprecipitation, confocal microscopy, deletion mutant analysis","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, domain mapping, confocal colocalization, multiple cell types","pmids":["9058808"],"is_preprint":false},{"year":1997,"finding":"BCR-associated tyrosine kinases Lyn and Syk synergistically phosphorylate HS1 at Tyr-378 and Tyr-397; mutation of these sites to phenylalanine abolishes BCR-induced apoptosis and prevents nuclear translocation of HS1, indicating tyrosine phosphorylation at these sites is required for apoptosis and nuclear targeting.","method":"Site-directed mutagenesis, transfection of M1 cells, apoptosis assay, subcellular localization by immunofluorescence","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis of specific phosphosites with functional apoptosis readout and localization data","pmids":["9104825"],"is_preprint":false},{"year":1999,"finding":"Tyr-222 is the HS1 residue phosphorylated by Src-family kinases c-Fgr and Lyn (secondary phosphorylation step); stable association of phospho-HS1 with c-Fgr requires prior Syk phosphorylation and c-Fgr autophosphorylation, and is prevented by subsequent Tyr-222 phosphorylation (i.e., once secondary phosphorylation is complete, the complex dissociates). The proline-rich region flanked by the Syk and Src target tyrosines functions as a sequential phosphorylation domain.","method":"Mass spectrometry peptide identification, in vitro kinase assay, co-immunoprecipitation, kinetic analysis with truncated HS1 forms","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with MS-based site identification and mechanistic dissection","pmids":["10066823"],"is_preprint":false},{"year":1999,"finding":"HS1 interacts with HS1BP3 via the HS1 SH3 domain; overexpression of a dominant-negative HS1BP3 in T cell lines reduces IL-2 production, suggesting HS1BP3 mediates HS1 signaling in lymphocyte activation.","method":"Yeast two-hybrid, co-immunoprecipitation, overexpression/dominant-negative in T cell lines, IL-2 assay","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP and functional overexpression with defined readout, single lab","pmids":["10590261"],"is_preprint":false},{"year":2000,"finding":"HS1 interacts directly with the Lyn SH3 domain via its proline-rich region; truncated HS1 bearing the Lyn-binding domain suppresses erythropoietin-induced proliferation and differentiation of erythroid cells, reduces Lyn and GATA-1 levels, and EPO stimulation triggers endosome-mediated degradation of HS1.","method":"Yeast two-hybrid, transfection of truncated HS1 in erythroleukemic cells, colony assay, morphological analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct interaction mapped, dominant-negative phenotype with specific functional readout","pmids":["10713104"],"is_preprint":false},{"year":2000,"finding":"CK2 phosphorylates HS1 at Ser/Thr residues (mainly threonyl) in the N-terminal and central regions; this Ser/Thr phosphorylation potentiates subsequent Tyr phosphorylation of HS1 by Syk/Src kinases.","method":"In vitro kinase assay with CK2, okadaic acid treatment of platelets, CK2 inhibitor treatment, deleted HS1 forms","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro reconstitution with deleted forms and pharmacological validation in cells","pmids":["10806407"],"is_preprint":false},{"year":2001,"finding":"Caspase-3 cleaves HS1 in a caspase-dependent manner during apoptosis; HS1 has two clusters of caspase cleavage sites—one in the actin-binding domain and one near the SH3 domain—and CK2-mediated phosphorylation of HS1 renders it resistant to caspase-3 cleavage.","method":"In vitro caspase cleavage assay, cell apoptosis assay with CK2 inhibitor TBB, anti-Fas and etoposide treatment","journal":"Biochemical and biophysical research communications / The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution plus cell-based assays with multiple apoptotic stimuli, two independent papers","pmids":["11689006","11988074"],"is_preprint":false},{"year":2003,"finding":"HS1 directly binds purified Arp2/3 complex (Kd ~880 nM) and F-actin (Kd ~400 nM), promotes Arp2/3-mediated actin polymerization and branched filament formation in vitro, and co-localizes with Arp2/3 complex in cells.","method":"Recombinant protein binding assay, pyrene actin polymerization assay, immunofluorescence co-localization","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with quantitative binding constants, multiple orthogonal assays","pmids":["12534372"],"is_preprint":false},{"year":2005,"finding":"The coiled-coil region of HS1 is required for binding to F-actin and for Arp2/3 complex activation; the repeat domain is needed for Arp2/3 binding; these two domains act synergistically. A peptide containing only the coiled-coil sequence is sufficient for F-actin binding. Wild-type HS1 co-localizes with cortical F-actin at the cell leading edge, while coiled-coil or repeat deletion mutants diffuse in the cytoplasm.","method":"Deletion mutagenesis, in vitro F-actin cosedimentation, Arp2/3 actin nucleation assay, GFP fusion live-cell imaging, co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — domain mutagenesis with in vitro reconstitution and cell imaging","pmids":["16157603"],"is_preprint":false},{"year":2005,"finding":"Thrombin stimulation of human platelets induces Syk-mediated primary phosphorylation of HS1 at Tyr397, enabling HS1 docking to the Lyn SH2 domain; Lyn then catalyzes secondary phosphorylation at Tyr222. This phosphorylation-dependent translocation of HS1 to the plasma membrane is required for cytoskeletal rearrangement in platelets.","method":"Pharmacological inhibitors (PP2, SU6656, piceatannol), phosphosite-specific antibodies, co-immunoprecipitation, immunofluorescence microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple inhibitors and phosphosite-specific tools; mechanistic dissection of ordered phosphorylation and translocation","pmids":["15795233"],"is_preprint":false},{"year":2006,"finding":"HS1-deficient T cells fail to accumulate F-actin at the immune synapse (IS) and form disordered, unstable actin-rich structures upon TCR ligation; Ca2+ influx and IL-2 gene transcription are defective. Tyrosine phosphorylation of HS1 is required for its targeting to the IS, for actin dynamics regulation, and for stable recruitment of Vav1 to the IS. HS1 phosphorylation links it to Lck, PLCγ1, and Vav1.","method":"HS1 KO T cells, live-cell actin imaging at IS, Ca2+ flux assay, IL-2 promoter reporter, phosphotyrosine mutant re-expression, co-immunoprecipitation","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — KO T cells with multiple orthogonal readouts plus mutant rescue and Co-IP interactome","pmids":["16782030"],"is_preprint":false},{"year":2007,"finding":"HS1 is phosphorylated downstream of glycoprotein VI (GPVI) in platelets by Src-family kinases; HS1 associates with Syk and PI3-kinases by co-immunoprecipitation. HS1-null mice show increased bleeding times, delayed thrombosis, impaired platelet aggregation and secretion downstream of GPVI and PAR-4, and reduced Akt phosphorylation.","method":"HS1-null mouse platelet assays (aggregation, secretion, bleeding time, FeCl3 thrombosis), co-immunoprecipitation, kinase inhibition","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — KO mouse with multiple specific platelet functional readouts and Co-IP binding partners","pmids":["17579181"],"is_preprint":false},{"year":2008,"finding":"In natural killer cells, HS1 is required for lytic synapse formation, cytolysis, adhesion, chemotaxis, and actin assembly. Tyr397 phosphorylation is specifically required for adhesion to ICAM-1 and cytolysis (integrin signaling and integrin/adaptor/actin recruitment to lytic synapse), while Tyr378 phosphorylation is required for chemotaxis—demonstrating distinct, separable functions for the two phosphotyrosines.","method":"HS1 knockdown in NK cells, phosphotyrosine-specific mutant re-expression, cytolysis assay, adhesion assay, chemotaxis assay, actin imaging","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — KD with site-specific mutant rescue, multiple orthogonal functional readouts","pmids":["18587398"],"is_preprint":false},{"year":2010,"finding":"HS1 controls cytoskeletal remodeling required for CLL B-cell migration, adhesion, and homing; HS1-silenced CLL cells show impaired in vitro migration, abnormal adhesion, and increased homotypic aggregation. In vivo, HS1-silenced CLL cells show decreased organ infiltration except bone marrow; Eμ-TCL1/HS1-KO mice show earlier disease onset and reduced survival.","method":"HS1 siRNA in MEC1 CLL cells, HS1-/- mouse B cells, in vitro migration/adhesion assays, in vivo xenograft in Rag2-/-γc-/- mice, Eμ-TCL1 x HS1-KO survival analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple model systems (human CLL, mouse KO), in vitro and in vivo phenotypes","pmids":["20530793"],"is_preprint":false},{"year":2011,"finding":"HS1 is required for receptor-mediated endocytosis (but not phagocytosis or macropinocytosis) in dendritic cells; HS1-/- DCs show defective antigen uptake and cross-presentation of protein antigen but normal peptide presentation. HS1 interacts with dynamin-2, and its loss decreases endocytic invaginations.","method":"HS1-/- DC functional assays, Ag uptake (endocytosis, phagocytosis, macropinocytosis), OVA protein/peptide presentation to T cells, co-immunoprecipitation with dynamin-2, EM analysis of endocytic intermediates","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — KO with multiple mechanistic phenotypes, Co-IP interaction, ultrastructural evidence","pmids":["22031761"],"is_preprint":false},{"year":2012,"finding":"HCLS1 is phosphorylated in response to G-CSF stimulation, binds the transcription factor LEF-1, and transports LEF-1 into the nucleus, inducing LEF-1 autoregulation. In HAX1-mutant severe congenital neutropenia patients, G-CSF-triggered HCLS1 phosphorylation is profoundly defective, leading to reduced LEF-1 expression and neutropenia. HCLS1-deficient mice are neutropenic.","method":"Co-immunoprecipitation (HCLS1–LEF-1), nuclear transport assay, G-CSF stimulation and phosphorylation analysis in human myeloid cells and patient samples, HCLS1-KO mouse analysis","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — Co-IP of HCLS1–LEF-1 complex, nuclear translocation assay, KO mice, patient samples; multiple orthogonal methods","pmids":["23001182"],"is_preprint":false},{"year":2012,"finding":"In neutrophils, HS1 localizes to the leading edge, is phosphorylated in response to fMLP, and is required for chemoattractant-induced Rac GTPase activation, Vav1 phosphorylation, and chemotaxis. Tyr222 (along with Tyr378 and Tyr397) phosphorylation regulates HS1–Arp2/3 interaction and is required for directional migration rescue.","method":"HS1 knockdown in PLB-985 neutrophil-like cells, live imaging in microchannels, Rac GTPase activation assay, Vav1 phosphorylation, phosphomutant re-expression, Arp2/3 co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — KD with phosphomutant rescue, multiple signaling and motility readouts","pmids":["22679023"],"is_preprint":false},{"year":2013,"finding":"LYN kinase phosphorylates HS1 at Tyr397 in a subset of CLL patients with activated LYN; this LYN/HS1 axis drives increased cytoskeletal functionality (migration, adhesion, F-actin polymerization), activates VAV1 and ERK, and promotes CLL cell survival. Dasatinib inhibition of LYN abrogates HS1-Y397 phosphorylation and reduces cytoskeletal activity and BCR signaling.","method":"Phosphosite-specific antibodies, dasatinib kinase inhibition, siRNA knockdown, migration/adhesion/F-actin assays, EμTCL1 transplantable mouse model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — multiple patient samples, pharmacological validation, in vivo mouse model, mechanistic pathway placement","pmids":["23325840"],"is_preprint":false},{"year":2014,"finding":"SDF1α (CXCL12)/CXCR4 signaling induces rapid Tyr378 phosphorylation of HS1, enabling it to associate with the Nck SH2 domain; this HS1-Nck complex promotes actin polymerization and T cell migration. Knockdown of either HS1 or Nck impairs SDF1α-induced actin polymerization and T-cell migration.","method":"Co-immunoprecipitation, siRNA knockdown of HS1 and Nck, actin polymerization assay, T cell migration assay, chemokine stimulation","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with phosphosite identification and dual-KD functional assay, single lab","pmids":["25359136"],"is_preprint":false},{"year":2017,"finding":"Wnt5a induces ROR1 to complex with HS1 via ROR1's proline-rich domain (PRD; specifically Pro841); this complex recruits ARHGEF1, activates RhoA, phosphorylates HS1 on Tyr, and enhances CLL cell F-actin polymerization and chemokine-directed migration. ROR1-P841A mutant cannot recruit HS1 or ARHGEF1 and fails to enhance motility.","method":"Co-immunoprecipitation, ROR1 domain truncation and point mutants, RhoA activation assay, F-actin assay, CLL cell migration assay, anti-ROR1 mAb (cirmtuzumab) inhibition","journal":"Leukemia","confidence":"High","confidence_rationale":"Tier 2 — Co-IP with domain mapping, point mutant validation, multiple functional readouts, ligand and antibody perturbation","pmids":["28465529"],"is_preprint":false},{"year":2017,"finding":"HS1 deficiency reduces neutrophil adhesion and transmigration in vivo (cremaster venule intravital microscopy) and impairs CXCL1-induced activation of Rac1 and Rap1 GTPases (with Rac1 acting upstream of Rap1), which are required for LFA-1-mediated neutrophil adhesion and extravasation.","method":"Intravital microscopy, HS1-KO and Rac1-KO neutrophils, GTPase activation assays, adhesion under flow, chemotaxis assay","journal":"Journal of leukocyte biology","confidence":"High","confidence_rationale":"Tier 2 — KO mouse in vivo with epistasis (Rac1 upstream of Rap1), multiple mechanistic readouts","pmids":["28122813"],"is_preprint":false},{"year":2011,"finding":"The HS1 SH3 domain binds lysine-rich class II PxxPxK proline motifs derived from HPK1; additional basic residues C-terminal to the PxxPxK core are required for binding. The SH3 domain alone and full-length HS1 bind the same peptide with similar affinity, indicating the SH3 domain governs this interaction.","method":"GST-SH3 fusion protein expression, circular dichroism-based non-immobilized ligand interaction assay, peptide mutagenesis, in silico modeling","journal":"Amino acids","confidence":"Medium","confidence_rationale":"Tier 1 — in vitro binding assay with quantitative affinity measurements and mutagenesis, single lab","pmids":["21287358"],"is_preprint":false},{"year":2019,"finding":"Human cytomegalovirus latency upregulates HCLS1 expression in CD14+ monocytes in a US28-dependent manner; elevated HCLS1 stabilizes actin structure, increases cell motility, and enhances transendothelial migration of latently infected cells.","method":"Proteomics of latently infected monocytes, US28 mutant virus, actin staining, transendothelial migration assay, HCLS1 knockdown","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2-3 — US28-dependent mechanism identified, functional KD with motility readout, single lab","pmids":["31569051"],"is_preprint":false},{"year":2004,"finding":"A four-amino-acid (EPEP) insertion polymorphism in HS1 at position 366-367 (in the proline-rich region) confers 100-fold greater sensitivity to BCR-mediated apoptosis in transfected WEHI-231 cells compared to wild-type HS1, indicating the proline-rich region modulates the strength of BCR apoptotic signaling.","method":"Transfection of HS1 variants into WEHI-231 cells, BCR crosslinking apoptosis assay, patient genomic analysis","journal":"Arthritis and rheumatism","confidence":"Medium","confidence_rationale":"Tier 2 — cell-based functional assay with specific HS1 variant, defined apoptosis phenotype","pmids":["15022330"],"is_preprint":false}],"current_model":"HCLS1/HS1 is a hematopoietic-specific actin-regulatory adaptor protein that functions downstream of multiple immune receptors (BCR, TCR, GPVI, CXCR4, ROR1): upon receptor stimulation, Syk phosphorylates HS1 at Tyr397 (primary phosphorylation), creating an SH2 docking site for Src-family kinases (Lyn, Lck, Fyn, c-Fgr) that catalyze secondary phosphorylation at Tyr222 and Tyr378; these phosphotyrosines recruit effectors including Vav1, Nck, ARHGEF1, Lck, and PLCγ1 to drive Arp2/3-complex-mediated actin polymerization via HS1's coiled-coil and repeat domains, and also enable nuclear translocation of LEF-1 for granulopoiesis; HS1 is additionally phosphorylated by CK2 on Ser/Thr (which potentiates Tyr phosphorylation and confers resistance to caspase-3 cleavage), and its HAX-1 binding partner connects it to mitochondrial survival signaling."},"narrative":{"teleology":[{"year":1993,"claim":"Identification of HS1 as a major tyrosine kinase substrate in BCR signaling and its association with Lyn established the protein as a signaling node downstream of the B-cell antigen receptor, opening the question of its functional role.","evidence":"Protein purification, peptide microsequencing, and reciprocal Co-IP from anti-IgM-stimulated B cells","pmids":["7682714"],"confidence":"High","gaps":["No functional phenotype yet assigned","Kinase-substrate relationship not mechanistically dissected","Downstream effectors unknown"]},{"year":1995,"claim":"Gene-targeted knockout and rescue experiments demonstrated that HS1 is essential for antigen receptor-induced clonal expansion and clonal deletion of lymphocytes, establishing that it is not merely a phosphorylation substrate but a required signal transducer for both proliferative and apoptotic outcomes of receptor engagement.","evidence":"HS1-knockout mice with proliferation/apoptosis assays; reconstitution of apoptosis sensitivity in HS1-deficient WEHI-231 B cells","pmids":["7641686","7638185"],"confidence":"High","gaps":["Mechanism by which HS1 controls apoptosis versus proliferation not resolved","Phosphorylation site requirements not mapped"]},{"year":1996,"claim":"Reconstitution of a sequential two-kinase phosphorylation mechanism—Syk performs primary phosphorylation creating SH2 docking sites for Src-family kinases that carry out secondary phosphorylation—resolved how HS1 integrates signals from distinct kinase families and revealed that SH2-phosphotyrosine docking, not catalytic-site specificity, governs the reaction order.","evidence":"In vitro kinase assays with phosphopeptide competition; Co-IP of Lck/Fyn SH2 and SH3 domains with HS1 in T cells","pmids":["8611520","8943564"],"confidence":"High","gaps":["Specific tyrosine residues not yet identified","In vivo significance of sequential phosphorylation not tested"]},{"year":1997,"claim":"Identification of Tyr378 and Tyr397 as the functionally critical phosphosites (required for BCR-induced apoptosis and nuclear translocation) and discovery of the HS1–HAX-1 interaction linked HS1 phosphorylation to specific cellular outcomes and to mitochondrial/survival signaling.","evidence":"Site-directed mutagenesis with apoptosis and localization readouts; yeast two-hybrid, reciprocal Co-IP, and confocal co-localization for HAX-1","pmids":["9104825","9058808"],"confidence":"High","gaps":["Which kinase phosphorylates which site in vivo unresolved","HAX-1 functional significance for HS1 not tested by loss-of-function"]},{"year":1999,"claim":"Mass spectrometry identification of Tyr222 as the Src-family kinase target site, and demonstration that complex dissociation follows secondary phosphorylation, revealed a self-limiting phosphorylation cycle that explained how HS1 could transiently integrate signals then release its kinase.","evidence":"MS-based peptide identification combined with in vitro kinase reconstitution and kinetic analysis","pmids":["10066823"],"confidence":"High","gaps":["Functional consequence of Tyr222 phosphorylation not yet tested in cells","Downstream effectors recruited by each phosphosite not identified"]},{"year":2000,"claim":"Discovery that CK2 phosphorylates HS1 on Ser/Thr residues and that this potentiates subsequent tyrosine phosphorylation introduced a cross-talk mechanism between constitutive and activation-induced phosphorylation cascades.","evidence":"In vitro CK2 kinase assays with deleted HS1 forms, okadaic acid and CK2 inhibitor treatment in platelets","pmids":["10806407"],"confidence":"Medium","gaps":["Specific Ser/Thr sites not mapped","In vivo CK2 requirement not demonstrated by genetic approach","Structural basis of potentiation unknown"]},{"year":2001,"claim":"Demonstration that caspase-3 cleaves HS1 at defined sites during apoptosis, and that CK2 phosphorylation protects against this cleavage, revealed a regulatory switch determining whether HS1 promotes survival signaling or is degraded during cell death.","evidence":"In vitro caspase cleavage assays, cell-based apoptosis with CK2 inhibitor TBB and multiple apoptotic stimuli","pmids":["11689006","11988074"],"confidence":"High","gaps":["Physiological relevance of caspase cleavage in immune cell selection not tested in vivo","Relative contributions of the two cleavage site clusters unknown"]},{"year":2003,"claim":"Direct binding of HS1 to purified Arp2/3 complex and F-actin, with quantitative affinities and demonstration of branched actin nucleation activity, established HS1 as a bona fide actin nucleation-promoting factor rather than merely a signaling scaffold.","evidence":"Recombinant protein binding assays (Kd measurements), pyrene actin polymerization, immunofluorescence co-localization","pmids":["12534372"],"confidence":"High","gaps":["Domain requirements for Arp2/3 activation not yet mapped","Relative contribution versus cortactin/N-WASP not addressed"]},{"year":2005,"claim":"Domain dissection showing that the coiled-coil region binds F-actin and the repeat domain binds Arp2/3, with synergistic activation, defined the minimal structural architecture enabling HS1's nucleation-promoting function and cortical localization.","evidence":"Deletion mutagenesis with in vitro F-actin cosedimentation, Arp2/3 nucleation assay, and live-cell GFP imaging","pmids":["16157603"],"confidence":"High","gaps":["No high-resolution structural data for HS1–Arp2/3 interface","How phosphorylation regulates domain function not addressed"]},{"year":2005,"claim":"Ordered Syk→Lyn phosphorylation at Tyr397→Tyr222 was recapitulated in platelets with phosphosite-specific antibodies, extending the two-kinase mechanism beyond B cells and demonstrating that phosphorylation-dependent plasma membrane translocation drives platelet cytoskeletal rearrangement.","evidence":"Pharmacological inhibitors, phosphosite-specific antibodies, Co-IP, and immunofluorescence in thrombin-stimulated human platelets","pmids":["15795233"],"confidence":"High","gaps":["No platelet-specific KO phenotype yet","Downstream platelet effectors not identified"]},{"year":2006,"claim":"HS1-knockout T cells revealed that HS1 is essential for F-actin accumulation and stability at the immune synapse, for Ca²⁺ influx, and for IL-2 transcription; phosphotyrosine-dependent recruitment of Vav1 to the IS established the link between HS1 phosphorylation and Rac/Rho GTPase activation at the synapse.","evidence":"HS1-KO T cells with live-cell actin imaging, Ca²⁺ flux, IL-2 reporter, phosphomutant re-expression, Co-IP","pmids":["16782030"],"confidence":"High","gaps":["How HS1 stabilizes versus initiates synapse actin not distinguished","Relative contribution of individual phosphosites in T cells not separated"]},{"year":2007,"claim":"HS1-null mice showed increased bleeding times and impaired platelet aggregation/secretion downstream of GPVI and PAR-4, establishing HS1 as functionally required for hemostasis and placing it in the GPVI→Syk→HS1 signaling axis in platelets.","evidence":"HS1-KO mouse platelet aggregation, secretion, bleeding time, FeCl₃ thrombosis model, Co-IP with Syk and PI3K","pmids":["17579181"],"confidence":"High","gaps":["Specific actin-dependent platelet process (spreading, clot retraction, secretion) controlled by HS1 not fully dissected"]},{"year":2008,"claim":"Separation-of-function analysis in NK cells demonstrated that Tyr397 selectively controls adhesion and cytolysis while Tyr378 controls chemotaxis, revealing that individual phosphotyrosines on HS1 recruit distinct effector complexes to drive different cellular outputs from the same scaffold.","evidence":"HS1 knockdown in NK cells with phosphosite-specific mutant re-expression; cytolysis, adhesion, and chemotaxis assays","pmids":["18587398"],"confidence":"High","gaps":["Identity of the effectors uniquely recruited by each phosphosite in NK cells not determined","Whether this phosphosite-function separation generalizes to all hematopoietic cells unknown"]},{"year":2010,"claim":"HS1 was shown to control CLL cell migration, adhesion, and in vivo homing, and HS1 loss in the Eμ-TCL1 mouse model accelerated disease, indicating that HS1's cytoskeletal functions restrain CLL progression—likely by retaining leukemic cells in tissue microenvironments.","evidence":"HS1 siRNA in CLL cells, HS1-KO mouse B cells, in vivo xenograft, Eμ-TCL1 × HS1-KO survival","pmids":["20530793"],"confidence":"High","gaps":["Mechanism by which HS1 loss accelerates CLL not resolved at molecular level","Whether HS1 phosphorylation status differs in indolent versus aggressive CLL not tested"]},{"year":2011,"claim":"HS1 was found to be required specifically for receptor-mediated endocytosis (not phagocytosis or macropinocytosis) in dendritic cells, interacting with dynamin-2 to support endocytic invaginations necessary for antigen cross-presentation, extending HS1's actin-regulatory role to membrane trafficking.","evidence":"HS1-KO DCs with endocytosis/phagocytosis/macropinocytosis assays, Co-IP with dynamin-2, EM of endocytic intermediates","pmids":["22031761"],"confidence":"High","gaps":["How HS1-Arp2/3 activity is directed specifically to endocytic sites unknown","Whether HS1 phosphorylation is required for endocytosis not tested"]},{"year":2012,"claim":"Two studies expanded HS1's role to granulopoiesis and neutrophil chemotaxis: HS1 binds LEF-1 and transports it into the nucleus to sustain G-CSF-driven granulopoiesis (defective in HAX1-mutant neutropenia patients), and phosphorylated HS1 regulates Rac activation, Vav1 phosphorylation, and Arp2/3 interaction to drive directional neutrophil migration.","evidence":"Co-IP of HCLS1–LEF-1, nuclear translocation assays, HAX1-mutant patient cells, HCLS1-KO mice neutropenia; HS1 KD in neutrophil-like cells with phosphomutant rescue, Rac/Vav1 assays","pmids":["23001182","22679023"],"confidence":"High","gaps":["Mechanism of HS1-mediated LEF-1 nuclear import not resolved","Whether HAX-1 directly regulates HS1 phosphorylation or acts indirectly unknown"]},{"year":2013,"claim":"LYN-mediated HS1-Tyr397 phosphorylation was identified as a driver of enhanced cytoskeletal function (migration, adhesion, F-actin) and survival in a subset of CLL patients, and dasatinib inhibition abrogated this axis, providing a pharmacologically targetable mechanism linking HS1 phosphorylation to disease pathogenesis.","evidence":"Phosphosite-specific antibodies, dasatinib inhibition, siRNA, migration/adhesion assays, Eμ-TCL1 transplant model","pmids":["23325840"],"confidence":"High","gaps":["Patient stratification criteria for LYN-active CLL not standardized","Downstream transcriptional consequences of ERK activation via HS1 not explored"]},{"year":2014,"claim":"Discovery that CXCR4/SDF1α signaling induces Tyr378 phosphorylation of HS1 to recruit Nck via its SH2 domain, promoting actin polymerization and T cell migration, identified a specific phosphosite–effector pairing downstream of chemokine receptors.","evidence":"Co-IP, siRNA knockdown of HS1 and Nck, actin polymerization and migration assays in T cells","pmids":["25359136"],"confidence":"Medium","gaps":["Kinase responsible for Tyr378 phosphorylation downstream of CXCR4 not identified","Whether Nck recruitment is direct or via an intermediate not fully resolved"]},{"year":2017,"claim":"Two studies placed HS1 in new signaling contexts: Wnt5a/ROR1 recruits HS1 via ROR1's proline-rich domain to activate ARHGEF1/RhoA and enhance CLL motility, and HS1-KO neutrophils showed defective Rac1→Rap1 activation required for LFA-1-dependent adhesion and extravasation in vivo.","evidence":"ROR1 domain mutants and Co-IP with HS1/ARHGEF1 in CLL cells; intravital microscopy of HS1-KO neutrophils, GTPase activation assays","pmids":["28465529","28122813"],"confidence":"High","gaps":["How HS1 bridges ROR1 to ARHGEF1 structurally unknown","Whether Rac1→Rap1 cascade is HS1-dependent in cell types beyond neutrophils not tested"]},{"year":null,"claim":"Major open questions include: the structural basis of HS1–Arp2/3 and HS1–F-actin interactions at atomic resolution; the identity of the kinase(s) phosphorylating HS1 downstream of chemokine receptors; how phosphosite-specific effector selection (Vav1 vs. Nck vs. ARHGEF1) is determined; and whether HS1's nuclear role with LEF-1 involves direct transcriptional regulation.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of HS1 or its complexes available","Phosphosite-to-effector selectivity code not defined","Nuclear function beyond LEF-1 transport uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[12,13,14,15,21]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,3,4,7,15,17,23,24]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[12,13,15,17,21]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[14,15,17]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[13]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,20]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,2,6,15,17,19,20,21,25]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4,7,14,22,23,24]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[14,16]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[1,2,6,11]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[20]}],"complexes":["Arp2/3 complex (functional partner, not stable subunit)"],"partners":["LYN","SYK","VAV1","HAX1","NCK1","ACTR2","DNM2","LEF1"],"other_free_text":[]},"mechanistic_narrative":"HCLS1 (HS1) is a hematopoietic-specific actin-regulatory adaptor protein that couples antigen receptor and chemokine receptor signaling to Arp2/3-complex-mediated actin polymerization, governing immune synapse formation, cell migration, adhesion, endocytosis, and both proliferative and apoptotic responses in lymphocytes, platelets, neutrophils, NK cells, and dendritic cells [PMID:7641686, PMID:16782030, PMID:17579181, PMID:18587398, PMID:22031761]. Upon receptor engagement, Syk phosphorylates HS1 at Tyr397, creating an SH2 docking site for Src-family kinases (Lyn, Lck, c-Fgr) that then phosphorylate Tyr222 and Tyr378 in a sequential two-kinase mechanism; these phosphotyrosines recruit distinct effectors—Vav1, Nck, ARHGEF1, PLCγ1—to drive actin remodeling, with Tyr397 selectively controlling adhesion/cytolysis and Tyr378 controlling chemotaxis [PMID:8611520, PMID:10066823, PMID:15795233, PMID:18587398, PMID:25359136, PMID:28465529]. HS1 directly binds F-actin via its coiled-coil domain and activates the Arp2/3 complex via its repeat domain to promote branched actin nucleation, while CK2-mediated Ser/Thr phosphorylation potentiates tyrosine phosphorylation and protects HS1 from caspase-3 cleavage during apoptosis [PMID:12534372, PMID:16157603, PMID:10806407, PMID:11689006]. HS1 also binds LEF-1 and transports it into the nucleus to sustain granulopoiesis downstream of G-CSF; defective HS1 phosphorylation in HAX1-mutant severe congenital neutropenia patients impairs this pathway, and HCLS1-deficient mice are neutropenic [PMID:23001182]."},"prefetch_data":{"uniprot":{"accession":"P14317","full_name":"Hematopoietic lineage cell-specific protein","aliases":["Hematopoietic cell-specific LYN substrate 1","LckBP1","p75"],"length_aa":486,"mass_kda":54.0,"function":"Substrate of the antigen receptor-coupled tyrosine kinase. Plays a role in antigen receptor signaling for both clonal expansion and deletion in lymphoid cells. May also be involved in the regulation of gene expression","subcellular_location":"Membrane; Cytoplasm; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/P14317/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HCLS1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HCLS1","total_profiled":1310},"omim":[{"mim_id":"613383","title":"ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 54; ANKRD54","url":"https://www.omim.org/entry/613383"},{"mim_id":"610738","title":"NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3","url":"https://www.omim.org/entry/610738"},{"mim_id":"605998","title":"HCLS1-ASSOCIATED PROTEIN X1; HAX1","url":"https://www.omim.org/entry/605998"},{"mim_id":"601306","title":"HEMATOPOIETIC CELL-SPECIFIC LYN SUBSTRATE 1; HCLS1","url":"https://www.omim.org/entry/601306"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":145.0},{"tissue":"lymphoid tissue","ntpm":290.6}],"url":"https://www.proteinatlas.org/search/HCLS1"},"hgnc":{"alias_symbol":["HS1","CTTNL"],"prev_symbol":[]},"alphafold":{"accession":"P14317","domains":[{"cath_id":"2.30.30.40","chopping":"432-486","consensus_level":"high","plddt":91.8564,"start":432,"end":486}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P14317","model_url":"https://alphafold.ebi.ac.uk/files/AF-P14317-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P14317-F1-predicted_aligned_error_v6.png","plddt_mean":63.59},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HCLS1","jax_strain_url":"https://www.jax.org/strain/search?query=HCLS1"},"sequence":{"accession":"P14317","fasta_url":"https://rest.uniprot.org/uniprotkb/P14317.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P14317/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P14317"}},"corpus_meta":[{"pmid":"9058808","id":"PMC_9058808","title":"HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9058808","citation_count":215,"is_preprint":false},{"pmid":"11988074","id":"PMC_11988074","title":"Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11988074","citation_count":193,"is_preprint":false},{"pmid":"16782030","id":"PMC_16782030","title":"HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse.","date":"2006","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/16782030","citation_count":169,"is_preprint":false},{"pmid":"7682714","id":"PMC_7682714","title":"Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7682714","citation_count":164,"is_preprint":false},{"pmid":"20538806","id":"PMC_20538806","title":"Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20538806","citation_count":121,"is_preprint":false},{"pmid":"17545607","id":"PMC_17545607","title":"HS1-associated protein X-1 regulates carcinoma cell migration and invasion via clathrin-mediated endocytosis of integrin alphavbeta6.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17545607","citation_count":117,"is_preprint":false},{"pmid":"7641686","id":"PMC_7641686","title":"Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7641686","citation_count":117,"is_preprint":false},{"pmid":"9104825","id":"PMC_9104825","title":"Role of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosis.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9104825","citation_count":91,"is_preprint":false},{"pmid":"16716149","id":"PMC_16716149","title":"Identification and functional characterization of hCLS1, a human cardiolipin synthase localized in mitochondria.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16716149","citation_count":79,"is_preprint":false},{"pmid":"11024139","id":"PMC_11024139","title":"Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.","date":"2000","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11024139","citation_count":79,"is_preprint":false},{"pmid":"23001182","id":"PMC_23001182","title":"Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis.","date":"2012","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23001182","citation_count":72,"is_preprint":false},{"pmid":"20530793","id":"PMC_20530793","title":"HS1 has a central role in the trafficking and homing of leukemic B cells.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20530793","citation_count":72,"is_preprint":false},{"pmid":"12534372","id":"PMC_12534372","title":"Haematopoietic lineage cell-specific protein 1 (HS1) promotes actin-related protein (Arp) 2/3 complex-mediated actin polymerization.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12534372","citation_count":68,"is_preprint":false},{"pmid":"15931393","id":"PMC_15931393","title":"HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.","date":"2005","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15931393","citation_count":62,"is_preprint":false},{"pmid":"11567985","id":"PMC_11567985","title":"Targeted deletion of 5'HS1 and 5'HS4 of the beta-globin locus control region reveals additive activity of the DNaseI hypersensitive sites.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11567985","citation_count":62,"is_preprint":false},{"pmid":"7638185","id":"PMC_7638185","title":"Restoration of surface IgM-mediated apoptosis in an anti-IgM-resistant variant of WEHI-231 lymphoma cells by HS1, a protein-tyrosine kinase substrate.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7638185","citation_count":61,"is_preprint":false},{"pmid":"7540628","id":"PMC_7540628","title":"Molecular subtyping scheme for serotypes HS1 and HS4 of Campylobacter jejuni.","date":"1995","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/7540628","citation_count":60,"is_preprint":false},{"pmid":"15699368","id":"PMC_15699368","title":"A variant in the HS1-BP3 gene is associated with familial essential tremor.","date":"2005","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/15699368","citation_count":57,"is_preprint":false},{"pmid":"17056081","id":"PMC_17056081","title":"Purification and characterization of Heteroscorpine-1 (HS-1) toxin from Heterometrus laoticus scorpion venom.","date":"2006","source":"Toxicon : official journal of the International Society on Toxinology","url":"https://pubmed.ncbi.nlm.nih.gov/17056081","citation_count":56,"is_preprint":false},{"pmid":"16547353","id":"PMC_16547353","title":"Cloning and characterization of a cDNA encoding human cardiolipin synthase (hCLS1).","date":"2006","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/16547353","citation_count":52,"is_preprint":false},{"pmid":"28465529","id":"PMC_28465529","title":"Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.","date":"2017","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/28465529","citation_count":51,"is_preprint":false},{"pmid":"9233627","id":"PMC_9233627","title":"Virtually identical enhancers containing a segment of homology to murine 3'IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9233627","citation_count":51,"is_preprint":false},{"pmid":"16645164","id":"PMC_16645164","title":"Flanking HS-62.5 and 3' HS1, and regions upstream of the LCR, are not required for beta-globin transcription.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16645164","citation_count":50,"is_preprint":false},{"pmid":"23325840","id":"PMC_23325840","title":"Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23325840","citation_count":48,"is_preprint":false},{"pmid":"7240090","id":"PMC_7240090","title":"Isolation and characterization of spontaneously occurring TOL plasmid mutants of Pseudomonas putida HS1.","date":"1981","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7240090","citation_count":48,"is_preprint":false},{"pmid":"15710041","id":"PMC_15710041","title":"Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain.","date":"2005","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15710041","citation_count":47,"is_preprint":false},{"pmid":"17921347","id":"PMC_17921347","title":"Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in beta-thalassemic mice.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17921347","citation_count":46,"is_preprint":false},{"pmid":"18587398","id":"PMC_18587398","title":"Differently phosphorylated forms of the cortactin homolog HS1 mediate distinct functions in natural killer cells.","date":"2008","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18587398","citation_count":46,"is_preprint":false},{"pmid":"8611520","id":"PMC_8611520","title":"SH2 domains mediate the sequential phosphorylation of HS1 protein by p72syk and Src-related protein tyrosine kinases.","date":"1996","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8611520","citation_count":45,"is_preprint":false},{"pmid":"9394827","id":"PMC_9394827","title":"Identification of a homolog of the C alpha 3'/hs3 enhancer and of an allelic variant of the 3'IgH/hs1,2 enhancer downstream of the human immunoglobulin alpha 1 gene.","date":"1997","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9394827","citation_count":43,"is_preprint":false},{"pmid":"12636258","id":"PMC_12636258","title":"Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.","date":"2003","source":"Microbiology and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12636258","citation_count":43,"is_preprint":false},{"pmid":"2432306","id":"PMC_2432306","title":"Ultrastructural, immunocytochemical, and cytogenetic characterization of a human epithelioid sarcoma cell line (RM-HS1).","date":"1987","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/2432306","citation_count":42,"is_preprint":false},{"pmid":"16157603","id":"PMC_16157603","title":"The coiled-coil domain is required for HS1 to bind to F-actin and activate Arp2/3 complex.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16157603","citation_count":41,"is_preprint":false},{"pmid":"10066823","id":"PMC_10066823","title":"Molecular features underlying the sequential phosphorylation of HS1 protein and its association with c-Fgr protein-tyrosine kinase.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10066823","citation_count":40,"is_preprint":false},{"pmid":"10713104","id":"PMC_10713104","title":"HS1 interacts with Lyn and is critical for erythropoietin-induced differentiation of erythroid cells.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10713104","citation_count":39,"is_preprint":false},{"pmid":"15545166","id":"PMC_15545166","title":"Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease.","date":"2004","source":"Scandinavian journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/15545166","citation_count":37,"is_preprint":false},{"pmid":"11544313","id":"PMC_11544313","title":"HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11544313","citation_count":36,"is_preprint":false},{"pmid":"8943564","id":"PMC_8943564","title":"Distinct binding patterns of HS1 to the Src SH2 and SH3 domains reflect possible mechanisms of recruitment and activation of downstream molecules.","date":"1996","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8943564","citation_count":35,"is_preprint":false},{"pmid":"11689006","id":"PMC_11689006","title":"Caspase-mediated cleavage of actin-binding and SH3-domain-containing proteins cortactin, HS1, and HIP-55 during apoptosis.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11689006","citation_count":35,"is_preprint":false},{"pmid":"11247602","id":"PMC_11247602","title":"High-resolution mapping of YACs and the single-copy gene Hs1(pro-1) on Beta vulgaris chromosomes by multi-colour fluorescence in situ hybridization.","date":"2001","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11247602","citation_count":35,"is_preprint":false},{"pmid":"8633077","id":"PMC_8633077","title":"Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2).","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8633077","citation_count":35,"is_preprint":false},{"pmid":"9230709","id":"PMC_9230709","title":"Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by the phthalocyanine Pc 4.","date":"1997","source":"Photochemistry and photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9230709","citation_count":33,"is_preprint":false},{"pmid":"18472110","id":"PMC_18472110","title":"Existence of multiple isoforms of HS1-associated protein X-1 in murine and human tissues.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18472110","citation_count":32,"is_preprint":false},{"pmid":"9657768","id":"PMC_9657768","title":"Full activity from human beta-globin locus control region transgenes requires 5'HS1, distal beta-globin promoter, and 3' beta-globin sequences.","date":"1998","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9657768","citation_count":32,"is_preprint":false},{"pmid":"22270371","id":"PMC_22270371","title":"Enhancers located in heavy chain regulatory region (hs3a, hs1,2, hs3b, and hs4) are dispensable for diversity of VDJ recombination.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22270371","citation_count":32,"is_preprint":false},{"pmid":"15716094","id":"PMC_15716094","title":"Evolution of human IgH3'EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor's consensus sites.","date":"2004","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15716094","citation_count":32,"is_preprint":false},{"pmid":"22679023","id":"PMC_22679023","title":"The actin regulatory protein HS1 interacts with Arp2/3 and mediates efficient neutrophil chemotaxis.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22679023","citation_count":31,"is_preprint":false},{"pmid":"30537294","id":"PMC_30537294","title":"Hematopoietic cell-specific lyn substrate (HCLS1 or HS1): A versatile actin-binding protein in leukocytes.","date":"2018","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/30537294","citation_count":30,"is_preprint":false},{"pmid":"22768161","id":"PMC_22768161","title":"HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22768161","citation_count":30,"is_preprint":false},{"pmid":"7535527","id":"PMC_7535527","title":"Molecular cloning and characterization of mouse HS1.","date":"1995","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/7535527","citation_count":30,"is_preprint":false},{"pmid":"15795233","id":"PMC_15795233","title":"Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the protein.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15795233","citation_count":30,"is_preprint":false},{"pmid":"27943080","id":"PMC_27943080","title":"Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).","date":"2016","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27943080","citation_count":29,"is_preprint":false},{"pmid":"19679660","id":"PMC_19679660","title":"N(alpha)-tosyl-L-phenylalanine chloromethyl ketone induces caspase-dependent apoptosis in transformed human B cell lines with transcriptional down-regulation of anti-apoptotic HS1-associated protein X-1.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19679660","citation_count":27,"is_preprint":false},{"pmid":"21406099","id":"PMC_21406099","title":"Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3'Regulatory Region.","date":"2011","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/21406099","citation_count":27,"is_preprint":false},{"pmid":"10590261","id":"PMC_10590261","title":"Isolation and characterization of a novel HS1 SH3 domain binding protein, HS1BP3.","date":"1999","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10590261","citation_count":26,"is_preprint":false},{"pmid":"15252056","id":"PMC_15252056","title":"The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3' hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15252056","citation_count":25,"is_preprint":false},{"pmid":"17579181","id":"PMC_17579181","title":"Hematopoietic lineage cell specific protein 1 (HS1) is a functionally important signaling molecule in platelet activation.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17579181","citation_count":24,"is_preprint":false},{"pmid":"22294636","id":"PMC_22294636","title":"Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus.","date":"2012","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22294636","citation_count":24,"is_preprint":false},{"pmid":"7507736","id":"PMC_7507736","title":"A novel deletion of approximately 27 kb including the beta-globin gene and the locus control region 3'HS-1 regulatory sequence: beta zero-thalassemia or hereditary persistence of fetal hemoglobin?","date":"1994","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/7507736","citation_count":24,"is_preprint":false},{"pmid":"9293770","id":"PMC_9293770","title":"Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.","date":"1997","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9293770","citation_count":24,"is_preprint":false},{"pmid":"17392350","id":"PMC_17392350","title":"Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency.","date":"2007","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/17392350","citation_count":24,"is_preprint":false},{"pmid":"7744027","id":"PMC_7744027","title":"Hierarchical phosphorylation of a 50-kDa protein by protein tyrosine kinases TPK-IIB and C-Fgr, and its identification as HS1 hematopoietic-lineage cell-specific protein.","date":"1995","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7744027","citation_count":23,"is_preprint":false},{"pmid":"18952640","id":"PMC_18952640","title":"Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis.","date":"2008","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18952640","citation_count":22,"is_preprint":false},{"pmid":"10072526","id":"PMC_10072526","title":"Ig heavy chain expression and class switching in vitro from an allele lacking the 3' enhancers DNase I-hypersensitive hs3A and hs1,2.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10072526","citation_count":22,"is_preprint":false},{"pmid":"16211613","id":"PMC_16211613","title":"HS1-BP3 gene variant is common in familial essential tremor.","date":"2006","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/16211613","citation_count":22,"is_preprint":false},{"pmid":"17996076","id":"PMC_17996076","title":"Studies on the actin-binding protein HS1 in platelets.","date":"2007","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17996076","citation_count":21,"is_preprint":false},{"pmid":"20007591","id":"PMC_20007591","title":"Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/20007591","citation_count":20,"is_preprint":false},{"pmid":"10528158","id":"PMC_10528158","title":"Cutting edge: Ig heavy chain 3' HS1-4 directs correct spatial position-independent expression of a linked transgene to B lineage cells.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10528158","citation_count":20,"is_preprint":false},{"pmid":"16818771","id":"PMC_16818771","title":"HS1-associated protein X-1 interacts with membrane-bound IgE: impact on receptor-mediated internalization.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16818771","citation_count":19,"is_preprint":false},{"pmid":"28122813","id":"PMC_28122813","title":"HS1 deficiency impairs neutrophil recruitment in vivo and activation of the small GTPases Rac1 and Rap1.","date":"2017","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/28122813","citation_count":18,"is_preprint":false},{"pmid":"25723543","id":"PMC_25723543","title":"Role of cortactin homolog HS1 in transendothelial migration of natural killer cells.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25723543","citation_count":18,"is_preprint":false},{"pmid":"9794375","id":"PMC_9794375","title":"Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9794375","citation_count":18,"is_preprint":false},{"pmid":"31569051","id":"PMC_31569051","title":"Human Cytomegalovirus Upregulates Expression of HCLS1 Resulting in Increased Cell Motility and Transendothelial Migration during Latency.","date":"2019","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/31569051","citation_count":18,"is_preprint":false},{"pmid":"22031761","id":"PMC_22031761","title":"The actin regulatory protein HS1 is required for antigen uptake and presentation by dendritic cells.","date":"2011","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22031761","citation_count":17,"is_preprint":false},{"pmid":"24376647","id":"PMC_24376647","title":"Suppressive effect of CORM-2 on LPS-induced platelet activation by glycoprotein mediated HS1 phosphorylation interference.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24376647","citation_count":17,"is_preprint":false},{"pmid":"10806407","id":"PMC_10806407","title":"Ser/Thr phosphorylation of hematopoietic specific protein 1 (HS1): implication of protein kinase CK2.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10806407","citation_count":17,"is_preprint":false},{"pmid":"8612628","id":"PMC_8612628","title":"A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1, c-Fgr and Lyn.","date":"1996","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8612628","citation_count":17,"is_preprint":false},{"pmid":"27778524","id":"PMC_27778524","title":"The actin binding proteins cortactin and HS1 are dispensable for platelet actin nodule and megakaryocyte podosome formation.","date":"2016","source":"Platelets","url":"https://pubmed.ncbi.nlm.nih.gov/27778524","citation_count":15,"is_preprint":false},{"pmid":"34585664","id":"PMC_34585664","title":"3'HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/34585664","citation_count":15,"is_preprint":false},{"pmid":"24804214","id":"PMC_24804214","title":"Streptomyces flavogriseus HS1: isolation and characterization of extracellular proteases and their compatibility with laundry detergents.","date":"2014","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/24804214","citation_count":15,"is_preprint":false},{"pmid":"19309558","id":"PMC_19309558","title":"Allelic frequencies of 3' Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia.","date":"2009","source":"International journal of immunopathology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19309558","citation_count":15,"is_preprint":false},{"pmid":"30788512","id":"PMC_30788512","title":"Improved growth performance due to hypertrophied intestinal absorptive epithelial cells by heat-killed Lactobacillus sakei HS-1 in broiler chickens1.","date":"2019","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/30788512","citation_count":15,"is_preprint":false},{"pmid":"21136158","id":"PMC_21136158","title":"Traumatic brain injury induces an up-regulation of Hs1-associated protein X-1 (Hax-1) in rat brain cortex.","date":"2010","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/21136158","citation_count":14,"is_preprint":false},{"pmid":"15022330","id":"PMC_15022330","title":"Association of a four-amino acid residue insertion polymorphism of the HS1 gene with systemic lupus erythematosus: molecular and functional analysis.","date":"2004","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/15022330","citation_count":14,"is_preprint":false},{"pmid":"35427779","id":"PMC_35427779","title":"ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candidaglabrata.","date":"2022","source":"Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases","url":"https://pubmed.ncbi.nlm.nih.gov/35427779","citation_count":14,"is_preprint":false},{"pmid":"16053712","id":"PMC_16053712","title":"Identification of p54(nrb) and the 14-3-3 Protein HS1 as TNF-alpha-inducible genes related to cell cycle control and apoptosis in human arterial endothelial cells.","date":"2005","source":"Journal of biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16053712","citation_count":14,"is_preprint":false},{"pmid":"12618860","id":"PMC_12618860","title":"Aberrant HS1 molecule in a patient with systemic lupus erythematosus.","date":"2003","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/12618860","citation_count":14,"is_preprint":false},{"pmid":"7927516","id":"PMC_7927516","title":"Tyrosine phosphorylation of MB-1, B29, and HS1 proteins in human B cells following receptor crosslinking.","date":"1994","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/7927516","citation_count":13,"is_preprint":false},{"pmid":"25359136","id":"PMC_25359136","title":"SDF1α-induced interaction of the adapter proteins Nck and HS1 facilitates actin polymerization and migration in T cells.","date":"2014","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25359136","citation_count":13,"is_preprint":false},{"pmid":"15234538","id":"PMC_15234538","title":"The polymorphism of the locus control region lying downstream the human IgH locus is restricted to hs1,2 but not to hs3 and hs4 enhancers.","date":"2004","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15234538","citation_count":13,"is_preprint":false},{"pmid":"28678266","id":"PMC_28678266","title":"The Arp2/3 complex binding protein HS1 is required for efficient dendritic cell random migration and force generation.","date":"2017","source":"Integrative biology : quantitative biosciences from nano to macro","url":"https://pubmed.ncbi.nlm.nih.gov/28678266","citation_count":13,"is_preprint":false},{"pmid":"19958188","id":"PMC_19958188","title":"Molecular analysis of gamma-globin promoters, HS-111 and 3'HS1, in beta-thalassemia intermedia patients associated with high levels of Hb F.","date":"2009","source":"Hemoglobin","url":"https://pubmed.ncbi.nlm.nih.gov/19958188","citation_count":12,"is_preprint":false},{"pmid":"22357631","id":"PMC_22357631","title":"2,3,7,8-tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3'Igh regulatory region.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22357631","citation_count":11,"is_preprint":false},{"pmid":"24384310","id":"PMC_24384310","title":"Feeding strategies for the improved biosynthesis of canthaxanthin from enzymatic hydrolyzed molasses in the fed-batch fermentation of Dietzia natronolimnaea HS-1.","date":"2013","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/24384310","citation_count":11,"is_preprint":false},{"pmid":"21287358","id":"PMC_21287358","title":"The SH3 domain of HS1 protein recognizes lysine-rich polyproline motifs.","date":"2011","source":"Amino acids","url":"https://pubmed.ncbi.nlm.nih.gov/21287358","citation_count":10,"is_preprint":false},{"pmid":"11282393","id":"PMC_11282393","title":"The lymphoid-specific cofactor OBF-1 is essential for the expression of a V(H) promoter/HS1,2 enhancer-linked transgene in late B cell development.","date":"2000","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11282393","citation_count":10,"is_preprint":false},{"pmid":"21301993","id":"PMC_21301993","title":"A novel PrP partner HS-1 associated protein X-1 (HAX-1) protected the cultured cells against the challenge of H₂O₂.","date":"2011","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/21301993","citation_count":10,"is_preprint":false},{"pmid":"25391515","id":"PMC_25391515","title":"The change in Ig regulation from children to adults disconnects the correlation with the 3'RR hs1.2 polymorphism.","date":"2014","source":"BMC immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25391515","citation_count":9,"is_preprint":false},{"pmid":"24177891","id":"PMC_24177891","title":"Construction of a YAC library from a Beta vulgaris fragment addition and isolation of a major satellite DNA cluster linked to the beet cyst nematode resistance locus Hs1 (pat-1.).","date":"1994","source":"TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik","url":"https://pubmed.ncbi.nlm.nih.gov/24177891","citation_count":9,"is_preprint":false},{"pmid":"30220969","id":"PMC_30220969","title":"Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30220969","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49909,"output_tokens":7300,"usd":0.129613},"stage2":{"model":"claude-opus-4-6","input_tokens":10992,"output_tokens":5214,"usd":0.277965},"total_usd":0.407578,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"HS1 (p75HS1) was identified as a major substrate of protein-tyrosine kinases in B-cell antigen receptor signaling, undergoing rapid tyrosine phosphorylation and associating with the Src-like kinase Lyn after crosslinking of membrane-bound IgM.\",\n      \"method\": \"Protein purification, peptide microsequencing, immunoprecipitation, Western blot\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with Lyn, peptide sequencing confirming identity, replicated in subsequent studies\",\n      \"pmids\": [\"7682714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"HS1-deficient mice generated by gene targeting showed impaired antigen receptor-induced clonal expansion of B and T cells and defective clonal deletion (thymic negative selection and peritoneal B cell apoptosis), establishing HS1 as essential for antigen receptor signaling pathways leading to both proliferation and apoptosis.\",\n      \"method\": \"Gene targeting (knockout mice), proliferation assays, apoptosis assays, crossing with TCR transgenic mice\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with multiple specific phenotypic readouts, foundational study\",\n      \"pmids\": [\"7641686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Re-expression of HS1 in an anti-IgM-resistant WEHI-231 variant (which had dramatically reduced HS1 levels) restored sensitivity to BCR-mediated apoptosis, demonstrating HS1 is required downstream of BCR for the apoptotic signal.\",\n      \"method\": \"Expression vector transfection, apoptosis assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function and rescue experiment with defined molecular phenotype\",\n      \"pmids\": [\"7638185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"p72Syk phosphorylates HS1 at sites containing motifs recognized by SH2 domains of Src kinases; this primary phosphorylation converts HS1 into a substrate for Src-family kinases (c-Fgr, Lyn, Fyn), which carry out secondary phosphorylation via SH2-domain-mediated docking. This sequential two-kinase mechanism requires SH2-phosphotyrosine interaction, not catalytic-site recognition.\",\n      \"method\": \"In vitro kinase assay, phosphopeptide competition, co-immunoprecipitation\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mechanistic dissection using phosphopeptide competition; replicated across multiple Src kinases\",\n      \"pmids\": [\"8611520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Lck SH3 domain binds HS1 constitutively via its proline-rich region, while the Lck SH2 domain associates with HS1 only upon TCR stimulation (after tyrosine phosphorylation); Fyn SH2 similarly binds phospho-HS1 upon TCR stimulation but Fyn SH3 does not interact.\",\n      \"method\": \"Co-immunoprecipitation, domain-binding analysis in T cell lines\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single-lab Co-IP with domain-level mapping, moderate mechanistic detail\",\n      \"pmids\": [\"8943564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"HS1 interacts directly with HAX-1 (a novel mitochondrial/ER/nuclear envelope protein); association is mediated by the N-terminal region of HS1 and the C-terminal half of HAX-1, confirmed by co-immunoprecipitation and co-localization.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, confocal microscopy, deletion mutant analysis\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, domain mapping, confocal colocalization, multiple cell types\",\n      \"pmids\": [\"9058808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"BCR-associated tyrosine kinases Lyn and Syk synergistically phosphorylate HS1 at Tyr-378 and Tyr-397; mutation of these sites to phenylalanine abolishes BCR-induced apoptosis and prevents nuclear translocation of HS1, indicating tyrosine phosphorylation at these sites is required for apoptosis and nuclear targeting.\",\n      \"method\": \"Site-directed mutagenesis, transfection of M1 cells, apoptosis assay, subcellular localization by immunofluorescence\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis of specific phosphosites with functional apoptosis readout and localization data\",\n      \"pmids\": [\"9104825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Tyr-222 is the HS1 residue phosphorylated by Src-family kinases c-Fgr and Lyn (secondary phosphorylation step); stable association of phospho-HS1 with c-Fgr requires prior Syk phosphorylation and c-Fgr autophosphorylation, and is prevented by subsequent Tyr-222 phosphorylation (i.e., once secondary phosphorylation is complete, the complex dissociates). The proline-rich region flanked by the Syk and Src target tyrosines functions as a sequential phosphorylation domain.\",\n      \"method\": \"Mass spectrometry peptide identification, in vitro kinase assay, co-immunoprecipitation, kinetic analysis with truncated HS1 forms\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with MS-based site identification and mechanistic dissection\",\n      \"pmids\": [\"10066823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"HS1 interacts with HS1BP3 via the HS1 SH3 domain; overexpression of a dominant-negative HS1BP3 in T cell lines reduces IL-2 production, suggesting HS1BP3 mediates HS1 signaling in lymphocyte activation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, overexpression/dominant-negative in T cell lines, IL-2 assay\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and functional overexpression with defined readout, single lab\",\n      \"pmids\": [\"10590261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HS1 interacts directly with the Lyn SH3 domain via its proline-rich region; truncated HS1 bearing the Lyn-binding domain suppresses erythropoietin-induced proliferation and differentiation of erythroid cells, reduces Lyn and GATA-1 levels, and EPO stimulation triggers endosome-mediated degradation of HS1.\",\n      \"method\": \"Yeast two-hybrid, transfection of truncated HS1 in erythroleukemic cells, colony assay, morphological analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct interaction mapped, dominant-negative phenotype with specific functional readout\",\n      \"pmids\": [\"10713104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CK2 phosphorylates HS1 at Ser/Thr residues (mainly threonyl) in the N-terminal and central regions; this Ser/Thr phosphorylation potentiates subsequent Tyr phosphorylation of HS1 by Syk/Src kinases.\",\n      \"method\": \"In vitro kinase assay with CK2, okadaic acid treatment of platelets, CK2 inhibitor treatment, deleted HS1 forms\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with deleted forms and pharmacological validation in cells\",\n      \"pmids\": [\"10806407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Caspase-3 cleaves HS1 in a caspase-dependent manner during apoptosis; HS1 has two clusters of caspase cleavage sites—one in the actin-binding domain and one near the SH3 domain—and CK2-mediated phosphorylation of HS1 renders it resistant to caspase-3 cleavage.\",\n      \"method\": \"In vitro caspase cleavage assay, cell apoptosis assay with CK2 inhibitor TBB, anti-Fas and etoposide treatment\",\n      \"journal\": \"Biochemical and biophysical research communications / The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution plus cell-based assays with multiple apoptotic stimuli, two independent papers\",\n      \"pmids\": [\"11689006\", \"11988074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HS1 directly binds purified Arp2/3 complex (Kd ~880 nM) and F-actin (Kd ~400 nM), promotes Arp2/3-mediated actin polymerization and branched filament formation in vitro, and co-localizes with Arp2/3 complex in cells.\",\n      \"method\": \"Recombinant protein binding assay, pyrene actin polymerization assay, immunofluorescence co-localization\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with quantitative binding constants, multiple orthogonal assays\",\n      \"pmids\": [\"12534372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The coiled-coil region of HS1 is required for binding to F-actin and for Arp2/3 complex activation; the repeat domain is needed for Arp2/3 binding; these two domains act synergistically. A peptide containing only the coiled-coil sequence is sufficient for F-actin binding. Wild-type HS1 co-localizes with cortical F-actin at the cell leading edge, while coiled-coil or repeat deletion mutants diffuse in the cytoplasm.\",\n      \"method\": \"Deletion mutagenesis, in vitro F-actin cosedimentation, Arp2/3 actin nucleation assay, GFP fusion live-cell imaging, co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain mutagenesis with in vitro reconstitution and cell imaging\",\n      \"pmids\": [\"16157603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Thrombin stimulation of human platelets induces Syk-mediated primary phosphorylation of HS1 at Tyr397, enabling HS1 docking to the Lyn SH2 domain; Lyn then catalyzes secondary phosphorylation at Tyr222. This phosphorylation-dependent translocation of HS1 to the plasma membrane is required for cytoskeletal rearrangement in platelets.\",\n      \"method\": \"Pharmacological inhibitors (PP2, SU6656, piceatannol), phosphosite-specific antibodies, co-immunoprecipitation, immunofluorescence microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitors and phosphosite-specific tools; mechanistic dissection of ordered phosphorylation and translocation\",\n      \"pmids\": [\"15795233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HS1-deficient T cells fail to accumulate F-actin at the immune synapse (IS) and form disordered, unstable actin-rich structures upon TCR ligation; Ca2+ influx and IL-2 gene transcription are defective. Tyrosine phosphorylation of HS1 is required for its targeting to the IS, for actin dynamics regulation, and for stable recruitment of Vav1 to the IS. HS1 phosphorylation links it to Lck, PLCγ1, and Vav1.\",\n      \"method\": \"HS1 KO T cells, live-cell actin imaging at IS, Ca2+ flux assay, IL-2 promoter reporter, phosphotyrosine mutant re-expression, co-immunoprecipitation\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO T cells with multiple orthogonal readouts plus mutant rescue and Co-IP interactome\",\n      \"pmids\": [\"16782030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HS1 is phosphorylated downstream of glycoprotein VI (GPVI) in platelets by Src-family kinases; HS1 associates with Syk and PI3-kinases by co-immunoprecipitation. HS1-null mice show increased bleeding times, delayed thrombosis, impaired platelet aggregation and secretion downstream of GPVI and PAR-4, and reduced Akt phosphorylation.\",\n      \"method\": \"HS1-null mouse platelet assays (aggregation, secretion, bleeding time, FeCl3 thrombosis), co-immunoprecipitation, kinase inhibition\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with multiple specific platelet functional readouts and Co-IP binding partners\",\n      \"pmids\": [\"17579181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In natural killer cells, HS1 is required for lytic synapse formation, cytolysis, adhesion, chemotaxis, and actin assembly. Tyr397 phosphorylation is specifically required for adhesion to ICAM-1 and cytolysis (integrin signaling and integrin/adaptor/actin recruitment to lytic synapse), while Tyr378 phosphorylation is required for chemotaxis—demonstrating distinct, separable functions for the two phosphotyrosines.\",\n      \"method\": \"HS1 knockdown in NK cells, phosphotyrosine-specific mutant re-expression, cytolysis assay, adhesion assay, chemotaxis assay, actin imaging\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KD with site-specific mutant rescue, multiple orthogonal functional readouts\",\n      \"pmids\": [\"18587398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HS1 controls cytoskeletal remodeling required for CLL B-cell migration, adhesion, and homing; HS1-silenced CLL cells show impaired in vitro migration, abnormal adhesion, and increased homotypic aggregation. In vivo, HS1-silenced CLL cells show decreased organ infiltration except bone marrow; Eμ-TCL1/HS1-KO mice show earlier disease onset and reduced survival.\",\n      \"method\": \"HS1 siRNA in MEC1 CLL cells, HS1-/- mouse B cells, in vitro migration/adhesion assays, in vivo xenograft in Rag2-/-γc-/- mice, Eμ-TCL1 x HS1-KO survival analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple model systems (human CLL, mouse KO), in vitro and in vivo phenotypes\",\n      \"pmids\": [\"20530793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"HS1 is required for receptor-mediated endocytosis (but not phagocytosis or macropinocytosis) in dendritic cells; HS1-/- DCs show defective antigen uptake and cross-presentation of protein antigen but normal peptide presentation. HS1 interacts with dynamin-2, and its loss decreases endocytic invaginations.\",\n      \"method\": \"HS1-/- DC functional assays, Ag uptake (endocytosis, phagocytosis, macropinocytosis), OVA protein/peptide presentation to T cells, co-immunoprecipitation with dynamin-2, EM analysis of endocytic intermediates\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with multiple mechanistic phenotypes, Co-IP interaction, ultrastructural evidence\",\n      \"pmids\": [\"22031761\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HCLS1 is phosphorylated in response to G-CSF stimulation, binds the transcription factor LEF-1, and transports LEF-1 into the nucleus, inducing LEF-1 autoregulation. In HAX1-mutant severe congenital neutropenia patients, G-CSF-triggered HCLS1 phosphorylation is profoundly defective, leading to reduced LEF-1 expression and neutropenia. HCLS1-deficient mice are neutropenic.\",\n      \"method\": \"Co-immunoprecipitation (HCLS1–LEF-1), nuclear transport assay, G-CSF stimulation and phosphorylation analysis in human myeloid cells and patient samples, HCLS1-KO mouse analysis\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of HCLS1–LEF-1 complex, nuclear translocation assay, KO mice, patient samples; multiple orthogonal methods\",\n      \"pmids\": [\"23001182\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In neutrophils, HS1 localizes to the leading edge, is phosphorylated in response to fMLP, and is required for chemoattractant-induced Rac GTPase activation, Vav1 phosphorylation, and chemotaxis. Tyr222 (along with Tyr378 and Tyr397) phosphorylation regulates HS1–Arp2/3 interaction and is required for directional migration rescue.\",\n      \"method\": \"HS1 knockdown in PLB-985 neutrophil-like cells, live imaging in microchannels, Rac GTPase activation assay, Vav1 phosphorylation, phosphomutant re-expression, Arp2/3 co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KD with phosphomutant rescue, multiple signaling and motility readouts\",\n      \"pmids\": [\"22679023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"LYN kinase phosphorylates HS1 at Tyr397 in a subset of CLL patients with activated LYN; this LYN/HS1 axis drives increased cytoskeletal functionality (migration, adhesion, F-actin polymerization), activates VAV1 and ERK, and promotes CLL cell survival. Dasatinib inhibition of LYN abrogates HS1-Y397 phosphorylation and reduces cytoskeletal activity and BCR signaling.\",\n      \"method\": \"Phosphosite-specific antibodies, dasatinib kinase inhibition, siRNA knockdown, migration/adhesion/F-actin assays, EμTCL1 transplantable mouse model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple patient samples, pharmacological validation, in vivo mouse model, mechanistic pathway placement\",\n      \"pmids\": [\"23325840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SDF1α (CXCL12)/CXCR4 signaling induces rapid Tyr378 phosphorylation of HS1, enabling it to associate with the Nck SH2 domain; this HS1-Nck complex promotes actin polymerization and T cell migration. Knockdown of either HS1 or Nck impairs SDF1α-induced actin polymerization and T-cell migration.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown of HS1 and Nck, actin polymerization assay, T cell migration assay, chemokine stimulation\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with phosphosite identification and dual-KD functional assay, single lab\",\n      \"pmids\": [\"25359136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Wnt5a induces ROR1 to complex with HS1 via ROR1's proline-rich domain (PRD; specifically Pro841); this complex recruits ARHGEF1, activates RhoA, phosphorylates HS1 on Tyr, and enhances CLL cell F-actin polymerization and chemokine-directed migration. ROR1-P841A mutant cannot recruit HS1 or ARHGEF1 and fails to enhance motility.\",\n      \"method\": \"Co-immunoprecipitation, ROR1 domain truncation and point mutants, RhoA activation assay, F-actin assay, CLL cell migration assay, anti-ROR1 mAb (cirmtuzumab) inhibition\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with domain mapping, point mutant validation, multiple functional readouts, ligand and antibody perturbation\",\n      \"pmids\": [\"28465529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HS1 deficiency reduces neutrophil adhesion and transmigration in vivo (cremaster venule intravital microscopy) and impairs CXCL1-induced activation of Rac1 and Rap1 GTPases (with Rac1 acting upstream of Rap1), which are required for LFA-1-mediated neutrophil adhesion and extravasation.\",\n      \"method\": \"Intravital microscopy, HS1-KO and Rac1-KO neutrophils, GTPase activation assays, adhesion under flow, chemotaxis assay\",\n      \"journal\": \"Journal of leukocyte biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse in vivo with epistasis (Rac1 upstream of Rap1), multiple mechanistic readouts\",\n      \"pmids\": [\"28122813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The HS1 SH3 domain binds lysine-rich class II PxxPxK proline motifs derived from HPK1; additional basic residues C-terminal to the PxxPxK core are required for binding. The SH3 domain alone and full-length HS1 bind the same peptide with similar affinity, indicating the SH3 domain governs this interaction.\",\n      \"method\": \"GST-SH3 fusion protein expression, circular dichroism-based non-immobilized ligand interaction assay, peptide mutagenesis, in silico modeling\",\n      \"journal\": \"Amino acids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding assay with quantitative affinity measurements and mutagenesis, single lab\",\n      \"pmids\": [\"21287358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Human cytomegalovirus latency upregulates HCLS1 expression in CD14+ monocytes in a US28-dependent manner; elevated HCLS1 stabilizes actin structure, increases cell motility, and enhances transendothelial migration of latently infected cells.\",\n      \"method\": \"Proteomics of latently infected monocytes, US28 mutant virus, actin staining, transendothelial migration assay, HCLS1 knockdown\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — US28-dependent mechanism identified, functional KD with motility readout, single lab\",\n      \"pmids\": [\"31569051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A four-amino-acid (EPEP) insertion polymorphism in HS1 at position 366-367 (in the proline-rich region) confers 100-fold greater sensitivity to BCR-mediated apoptosis in transfected WEHI-231 cells compared to wild-type HS1, indicating the proline-rich region modulates the strength of BCR apoptotic signaling.\",\n      \"method\": \"Transfection of HS1 variants into WEHI-231 cells, BCR crosslinking apoptosis assay, patient genomic analysis\",\n      \"journal\": \"Arthritis and rheumatism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based functional assay with specific HS1 variant, defined apoptosis phenotype\",\n      \"pmids\": [\"15022330\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HCLS1/HS1 is a hematopoietic-specific actin-regulatory adaptor protein that functions downstream of multiple immune receptors (BCR, TCR, GPVI, CXCR4, ROR1): upon receptor stimulation, Syk phosphorylates HS1 at Tyr397 (primary phosphorylation), creating an SH2 docking site for Src-family kinases (Lyn, Lck, Fyn, c-Fgr) that catalyze secondary phosphorylation at Tyr222 and Tyr378; these phosphotyrosines recruit effectors including Vav1, Nck, ARHGEF1, Lck, and PLCγ1 to drive Arp2/3-complex-mediated actin polymerization via HS1's coiled-coil and repeat domains, and also enable nuclear translocation of LEF-1 for granulopoiesis; HS1 is additionally phosphorylated by CK2 on Ser/Thr (which potentiates Tyr phosphorylation and confers resistance to caspase-3 cleavage), and its HAX-1 binding partner connects it to mitochondrial survival signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HCLS1 (HS1) is a hematopoietic-specific actin-regulatory adaptor protein that couples antigen receptor and chemokine receptor signaling to Arp2/3-complex-mediated actin polymerization, governing immune synapse formation, cell migration, adhesion, endocytosis, and both proliferative and apoptotic responses in lymphocytes, platelets, neutrophils, NK cells, and dendritic cells [PMID:7641686, PMID:16782030, PMID:17579181, PMID:18587398, PMID:22031761]. Upon receptor engagement, Syk phosphorylates HS1 at Tyr397, creating an SH2 docking site for Src-family kinases (Lyn, Lck, c-Fgr) that then phosphorylate Tyr222 and Tyr378 in a sequential two-kinase mechanism; these phosphotyrosines recruit distinct effectors—Vav1, Nck, ARHGEF1, PLCγ1—to drive actin remodeling, with Tyr397 selectively controlling adhesion/cytolysis and Tyr378 controlling chemotaxis [PMID:8611520, PMID:10066823, PMID:15795233, PMID:18587398, PMID:25359136, PMID:28465529]. HS1 directly binds F-actin via its coiled-coil domain and activates the Arp2/3 complex via its repeat domain to promote branched actin nucleation, while CK2-mediated Ser/Thr phosphorylation potentiates tyrosine phosphorylation and protects HS1 from caspase-3 cleavage during apoptosis [PMID:12534372, PMID:16157603, PMID:10806407, PMID:11689006]. HS1 also binds LEF-1 and transports it into the nucleus to sustain granulopoiesis downstream of G-CSF; defective HS1 phosphorylation in HAX1-mutant severe congenital neutropenia patients impairs this pathway, and HCLS1-deficient mice are neutropenic [PMID:23001182].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of HS1 as a major tyrosine kinase substrate in BCR signaling and its association with Lyn established the protein as a signaling node downstream of the B-cell antigen receptor, opening the question of its functional role.\",\n      \"evidence\": \"Protein purification, peptide microsequencing, and reciprocal Co-IP from anti-IgM-stimulated B cells\",\n      \"pmids\": [\"7682714\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional phenotype yet assigned\", \"Kinase-substrate relationship not mechanistically dissected\", \"Downstream effectors unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Gene-targeted knockout and rescue experiments demonstrated that HS1 is essential for antigen receptor-induced clonal expansion and clonal deletion of lymphocytes, establishing that it is not merely a phosphorylation substrate but a required signal transducer for both proliferative and apoptotic outcomes of receptor engagement.\",\n      \"evidence\": \"HS1-knockout mice with proliferation/apoptosis assays; reconstitution of apoptosis sensitivity in HS1-deficient WEHI-231 B cells\",\n      \"pmids\": [\"7641686\", \"7638185\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which HS1 controls apoptosis versus proliferation not resolved\", \"Phosphorylation site requirements not mapped\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Reconstitution of a sequential two-kinase phosphorylation mechanism—Syk performs primary phosphorylation creating SH2 docking sites for Src-family kinases that carry out secondary phosphorylation—resolved how HS1 integrates signals from distinct kinase families and revealed that SH2-phosphotyrosine docking, not catalytic-site specificity, governs the reaction order.\",\n      \"evidence\": \"In vitro kinase assays with phosphopeptide competition; Co-IP of Lck/Fyn SH2 and SH3 domains with HS1 in T cells\",\n      \"pmids\": [\"8611520\", \"8943564\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific tyrosine residues not yet identified\", \"In vivo significance of sequential phosphorylation not tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identification of Tyr378 and Tyr397 as the functionally critical phosphosites (required for BCR-induced apoptosis and nuclear translocation) and discovery of the HS1–HAX-1 interaction linked HS1 phosphorylation to specific cellular outcomes and to mitochondrial/survival signaling.\",\n      \"evidence\": \"Site-directed mutagenesis with apoptosis and localization readouts; yeast two-hybrid, reciprocal Co-IP, and confocal co-localization for HAX-1\",\n      \"pmids\": [\"9104825\", \"9058808\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which kinase phosphorylates which site in vivo unresolved\", \"HAX-1 functional significance for HS1 not tested by loss-of-function\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mass spectrometry identification of Tyr222 as the Src-family kinase target site, and demonstration that complex dissociation follows secondary phosphorylation, revealed a self-limiting phosphorylation cycle that explained how HS1 could transiently integrate signals then release its kinase.\",\n      \"evidence\": \"MS-based peptide identification combined with in vitro kinase reconstitution and kinetic analysis\",\n      \"pmids\": [\"10066823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Tyr222 phosphorylation not yet tested in cells\", \"Downstream effectors recruited by each phosphosite not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that CK2 phosphorylates HS1 on Ser/Thr residues and that this potentiates subsequent tyrosine phosphorylation introduced a cross-talk mechanism between constitutive and activation-induced phosphorylation cascades.\",\n      \"evidence\": \"In vitro CK2 kinase assays with deleted HS1 forms, okadaic acid and CK2 inhibitor treatment in platelets\",\n      \"pmids\": [\"10806407\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific Ser/Thr sites not mapped\", \"In vivo CK2 requirement not demonstrated by genetic approach\", \"Structural basis of potentiation unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstration that caspase-3 cleaves HS1 at defined sites during apoptosis, and that CK2 phosphorylation protects against this cleavage, revealed a regulatory switch determining whether HS1 promotes survival signaling or is degraded during cell death.\",\n      \"evidence\": \"In vitro caspase cleavage assays, cell-based apoptosis with CK2 inhibitor TBB and multiple apoptotic stimuli\",\n      \"pmids\": [\"11689006\", \"11988074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of caspase cleavage in immune cell selection not tested in vivo\", \"Relative contributions of the two cleavage site clusters unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Direct binding of HS1 to purified Arp2/3 complex and F-actin, with quantitative affinities and demonstration of branched actin nucleation activity, established HS1 as a bona fide actin nucleation-promoting factor rather than merely a signaling scaffold.\",\n      \"evidence\": \"Recombinant protein binding assays (Kd measurements), pyrene actin polymerization, immunofluorescence co-localization\",\n      \"pmids\": [\"12534372\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Domain requirements for Arp2/3 activation not yet mapped\", \"Relative contribution versus cortactin/N-WASP not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Domain dissection showing that the coiled-coil region binds F-actin and the repeat domain binds Arp2/3, with synergistic activation, defined the minimal structural architecture enabling HS1's nucleation-promoting function and cortical localization.\",\n      \"evidence\": \"Deletion mutagenesis with in vitro F-actin cosedimentation, Arp2/3 nucleation assay, and live-cell GFP imaging\",\n      \"pmids\": [\"16157603\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structural data for HS1–Arp2/3 interface\", \"How phosphorylation regulates domain function not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Ordered Syk→Lyn phosphorylation at Tyr397→Tyr222 was recapitulated in platelets with phosphosite-specific antibodies, extending the two-kinase mechanism beyond B cells and demonstrating that phosphorylation-dependent plasma membrane translocation drives platelet cytoskeletal rearrangement.\",\n      \"evidence\": \"Pharmacological inhibitors, phosphosite-specific antibodies, Co-IP, and immunofluorescence in thrombin-stimulated human platelets\",\n      \"pmids\": [\"15795233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No platelet-specific KO phenotype yet\", \"Downstream platelet effectors not identified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"HS1-knockout T cells revealed that HS1 is essential for F-actin accumulation and stability at the immune synapse, for Ca²⁺ influx, and for IL-2 transcription; phosphotyrosine-dependent recruitment of Vav1 to the IS established the link between HS1 phosphorylation and Rac/Rho GTPase activation at the synapse.\",\n      \"evidence\": \"HS1-KO T cells with live-cell actin imaging, Ca²⁺ flux, IL-2 reporter, phosphomutant re-expression, Co-IP\",\n      \"pmids\": [\"16782030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HS1 stabilizes versus initiates synapse actin not distinguished\", \"Relative contribution of individual phosphosites in T cells not separated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"HS1-null mice showed increased bleeding times and impaired platelet aggregation/secretion downstream of GPVI and PAR-4, establishing HS1 as functionally required for hemostasis and placing it in the GPVI→Syk→HS1 signaling axis in platelets.\",\n      \"evidence\": \"HS1-KO mouse platelet aggregation, secretion, bleeding time, FeCl₃ thrombosis model, Co-IP with Syk and PI3K\",\n      \"pmids\": [\"17579181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific actin-dependent platelet process (spreading, clot retraction, secretion) controlled by HS1 not fully dissected\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Separation-of-function analysis in NK cells demonstrated that Tyr397 selectively controls adhesion and cytolysis while Tyr378 controls chemotaxis, revealing that individual phosphotyrosines on HS1 recruit distinct effector complexes to drive different cellular outputs from the same scaffold.\",\n      \"evidence\": \"HS1 knockdown in NK cells with phosphosite-specific mutant re-expression; cytolysis, adhesion, and chemotaxis assays\",\n      \"pmids\": [\"18587398\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the effectors uniquely recruited by each phosphosite in NK cells not determined\", \"Whether this phosphosite-function separation generalizes to all hematopoietic cells unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"HS1 was shown to control CLL cell migration, adhesion, and in vivo homing, and HS1 loss in the Eμ-TCL1 mouse model accelerated disease, indicating that HS1's cytoskeletal functions restrain CLL progression—likely by retaining leukemic cells in tissue microenvironments.\",\n      \"evidence\": \"HS1 siRNA in CLL cells, HS1-KO mouse B cells, in vivo xenograft, Eμ-TCL1 × HS1-KO survival\",\n      \"pmids\": [\"20530793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which HS1 loss accelerates CLL not resolved at molecular level\", \"Whether HS1 phosphorylation status differs in indolent versus aggressive CLL not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"HS1 was found to be required specifically for receptor-mediated endocytosis (not phagocytosis or macropinocytosis) in dendritic cells, interacting with dynamin-2 to support endocytic invaginations necessary for antigen cross-presentation, extending HS1's actin-regulatory role to membrane trafficking.\",\n      \"evidence\": \"HS1-KO DCs with endocytosis/phagocytosis/macropinocytosis assays, Co-IP with dynamin-2, EM of endocytic intermediates\",\n      \"pmids\": [\"22031761\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HS1-Arp2/3 activity is directed specifically to endocytic sites unknown\", \"Whether HS1 phosphorylation is required for endocytosis not tested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Two studies expanded HS1's role to granulopoiesis and neutrophil chemotaxis: HS1 binds LEF-1 and transports it into the nucleus to sustain G-CSF-driven granulopoiesis (defective in HAX1-mutant neutropenia patients), and phosphorylated HS1 regulates Rac activation, Vav1 phosphorylation, and Arp2/3 interaction to drive directional neutrophil migration.\",\n      \"evidence\": \"Co-IP of HCLS1–LEF-1, nuclear translocation assays, HAX1-mutant patient cells, HCLS1-KO mice neutropenia; HS1 KD in neutrophil-like cells with phosphomutant rescue, Rac/Vav1 assays\",\n      \"pmids\": [\"23001182\", \"22679023\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of HS1-mediated LEF-1 nuclear import not resolved\", \"Whether HAX-1 directly regulates HS1 phosphorylation or acts indirectly unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"LYN-mediated HS1-Tyr397 phosphorylation was identified as a driver of enhanced cytoskeletal function (migration, adhesion, F-actin) and survival in a subset of CLL patients, and dasatinib inhibition abrogated this axis, providing a pharmacologically targetable mechanism linking HS1 phosphorylation to disease pathogenesis.\",\n      \"evidence\": \"Phosphosite-specific antibodies, dasatinib inhibition, siRNA, migration/adhesion assays, Eμ-TCL1 transplant model\",\n      \"pmids\": [\"23325840\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Patient stratification criteria for LYN-active CLL not standardized\", \"Downstream transcriptional consequences of ERK activation via HS1 not explored\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that CXCR4/SDF1α signaling induces Tyr378 phosphorylation of HS1 to recruit Nck via its SH2 domain, promoting actin polymerization and T cell migration, identified a specific phosphosite–effector pairing downstream of chemokine receptors.\",\n      \"evidence\": \"Co-IP, siRNA knockdown of HS1 and Nck, actin polymerization and migration assays in T cells\",\n      \"pmids\": [\"25359136\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase responsible for Tyr378 phosphorylation downstream of CXCR4 not identified\", \"Whether Nck recruitment is direct or via an intermediate not fully resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Two studies placed HS1 in new signaling contexts: Wnt5a/ROR1 recruits HS1 via ROR1's proline-rich domain to activate ARHGEF1/RhoA and enhance CLL motility, and HS1-KO neutrophils showed defective Rac1→Rap1 activation required for LFA-1-dependent adhesion and extravasation in vivo.\",\n      \"evidence\": \"ROR1 domain mutants and Co-IP with HS1/ARHGEF1 in CLL cells; intravital microscopy of HS1-KO neutrophils, GTPase activation assays\",\n      \"pmids\": [\"28465529\", \"28122813\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HS1 bridges ROR1 to ARHGEF1 structurally unknown\", \"Whether Rac1→Rap1 cascade is HS1-dependent in cell types beyond neutrophils not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include: the structural basis of HS1–Arp2/3 and HS1–F-actin interactions at atomic resolution; the identity of the kinase(s) phosphorylating HS1 downstream of chemokine receptors; how phosphosite-specific effector selection (Vav1 vs. Nck vs. ARHGEF1) is determined; and whether HS1's nuclear role with LEF-1 involves direct transcriptional regulation.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of HS1 or its complexes available\", \"Phosphosite-to-effector selectivity code not defined\", \"Nuclear function beyond LEF-1 transport uncharacterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [12, 13, 14, 15, 21]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 3, 4, 7, 15, 17, 23, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [12, 13, 15, 17, 21]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [14, 15, 17]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 2, 6, 15, 17, 19, 20, 21, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4, 7, 14, 22, 23, 24]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [14, 16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [1, 2, 6, 11]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"complexes\": [\n      \"Arp2/3 complex (functional partner, not stable subunit)\"\n    ],\n    \"partners\": [\n      \"LYN\",\n      \"SYK\",\n      \"VAV1\",\n      \"HAX1\",\n      \"NCK1\",\n      \"ACTR2\",\n      \"DNM2\",\n      \"LEF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}